Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 1,034.00
Price - 52 Week High 1,489.00
Price - 52 Week Low 1,015.00
Price Date (Latest) Dec 14, 2017
Median Price Target 1,507.50
Diff from Prev Close 473.50
% Difference 45.79%

Reference Information

Last Actual (FY0) 19.22
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 68.63 %
Hist (5 Yr) Stability % 177.00 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
52.40 90.30 36.57 50.56 16 2 0 1.25 %
Annual
Dec '18
33.17 44.90 22.10 33.33 15 0 3 0.14 %
Annual
Dec '17
17.74 22.11 13.80 17.52 16 0 2 1.59 %
Quarterly
Sep '17
2.82 5.15 0.70 2.43 5 0 0 -3.31 %
Quarterly
Dec '17
6.00 10.11 2.76 5.50 5 0 1 -19.57 %
Quarterly
Mar '18
0.00 0.00 0.00 0.00 1 0 0 N/A
Long Term Growth
N/A
37.87 43.70 34.00 35.90 3 1 1 -  

 

Actuals

Fiscal Period Reported EPS Mean Estimates Surprise % Change
Annual
Dec '16
19.22 15.79 21.70 %
Quarterly
Sep '16
3.06 1.11 175.18 %
Quarterly
Dec '16
13.62 7.36 85.12 %
Quarterly
Mar '17
0.26 -0.19 240.54 %
Quarterly
Jun '17
4.95 7.03 -29.57 %
Annual
Dec '15
12.56 11.26 11.54 %
Annual
Dec '14
5.26 4.05 29.88 %

 

P/E Ratios

Genmab A/S - eafe hea multi-industry

Fiscal Period Genmab A/S eafe hea multi-industry Industry Relative
FY0 74.30 57.39 1.29
FY1 80.51 62.19 1.29
FY2 43.05 33.25 1.29

 

EPS Growth Rates

Genmab A/S - eafe hea multi-industry

Growth Rates Genmab A/S eafe hea multi-industry Industry Relative
FY1/FY0 -7.72 -7.72 1.00
FY2/FY1 87.02 87.02 1.00
FY3/FY2 57.97 57.97 1.00

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Genmab A/S. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in DKK